Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Multiple Myeloma 15Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Lymphoma, Non-Hodgkin 6Burkitt Lymphoma 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Astrocytoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Acute 3Hematologic Diseases 3Waldenstrom Macroglobulinemia 2Uveal Melanoma 2Smoldering Multiple Myeloma 2Sezary Syndrome 2Optic Nerve Glioma 2Oligodendroglioma 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Promyelocytic, Acute 2

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 3Methotrexate 3Filgrastim 3Etoposide 3Cytarabine 3Busulfan 3sargramostim 2merphos 2Vorinostat 2Idarubicin 2Granulocyte-Macrophage Colony-Stimulating Factor 2Decitabine 2Cyclosporine 2tipifarnib 1palmitoyl-L-asparaginase 1entinostat 1bryostatin 1 1aldesleukin 1Vitamin E 1Transplantation 1Topotecan 1Thioguanine 1Thalidomide 1Tacrolimus 1Radiotherapy, Conformal 1Methylprednisolone 1Lenalidomide 1Isotretinoin 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia, Refractory × Lenalidomide × Clear all
NCT00104962 2014-06-11

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Classical hematology

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡